Experimental Design, Setting, and Eligibility Criteria

GV G. Vaisson
HW H.O. Witteman
SC S. Chipenda-Dansokho
MS M. Saragosa
ZB Z. Bouck
CB C.A. Bravo
LD L. Desveaux
DL D. Llovet
JP J. Presseau
MT M. Taljaard
SU S. Umar
JG J.M. Grimshaw
JT J. Tinmouth
NI N.M. Ivers
ask Ask a question
Favorite

Participants in this 2×2×2 randomized factorial experiment were primary care physicians (5449 in May 2017) who had accepted to receive routine e-mail messages about the Screening Activity Report. Nominated delegates (that is, people designated to access the Screening Activity Report on behalf of eligible physicians) were excluded, a decision that was made because of uncertainties in attributing the intervention to Screening Activity Report access by a delegate (that is, risk of contamination). The Research Ethics Board at Women’s College Hospital approved the study, with a waiver of informed consent for physician participation, given that the study met all Article 3.7A criteria of the Tri-Council Policy Statement26,27. The study is registered at http://ClinicalTrials.gov/ as NCT03124316.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A